Guam Memorial Hospital Authority said it received recertification of its respiratory services under the Clinical Laboratory ...

Palo Alto lab enables faster turnaround times and increased capacity for ultrasensitive, amplicon-based liquid biopsy testing for US customers PALO ALTO, Calif.--(BUSINESS WIRE)--Molecular diagnostics ...

Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...

Biodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro diagnostic (IVD) assays, designed to facilitate the identification of a ...

U.S. Senator Rand Paul introduced legislation that would place laboratory developed testing procedures within the Clinical Laboratory Improvement Amendments (CLIA) process and assess the availability ...

Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. (EDI) to offer the ECL100, a fully automated chemiluminescent immunoassay analyzer, and 50+ CLIA kits to laboratories across North ...

Clinical Laboratory Improvement Amendments, or CLIA, are a high bar as set by the US Government under Clinical Laboratory Improvement Amendment 42 CFR 493.1253 to obtain and maintain quality ...

Comprehensive pharmacogenetic assay focused on psychiatry and neurology advances precision medicine for the brain. KEARNY, N.J., Nov. 21, 2024 /PRNewswire/ -- NeuroKaire, a pioneering biotechnology ...

Marlborough, Mass.-based Akoya Biosciences was awarded CLIA certification for its Advanced Biopharma Solutions lab, the company said in a Nov. 30 news release. The lab specializes in spatial biology, ...

NATICK, Mass.--(BUSINESS WIRE)--Pillar Biosciences, an innovative, next-generation sequencing (NGS) solutions, in-vitro diagnostics (IVD) company, today announced that its NGS laboratory, located in ...

The Respiratory Laboratory at the Guam Memorial Hospital Authority has earned recertification of its respiratory services ...

DENVER, CO / ACCESSWIRE / September 9, 2020 / OncBioMune d/b/a Theralink Technologies (OTC PINK:OBMP), a molecular profiling company specializing in patented, biomarker assay services that target ...